Evaluation of an improved rapid neutralizing antibody detection test (RAPINA) for qualitative and semiquantitative detection of rabies neutralizing antibody in humans and dogs

Vaccine

Volumn 30, Issue 26, 2012, Pages 3891-3896

  Nishizono, Akira ^a   Yamada, Kentaro ^b   Khawplod, Pakamatz ^c   Shiota, Seiji ^a   Perera, Devika ^d   Matsumoto, Takashi ^a   Wimalaratne, Omala ^d   Mitui, Marcelo Takahiro ^a   Ahmed, Kamruddin ^b  

^a OITA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^d MINISTRY OF HEALTH   (Sri Lanka)

Author keywords

Immunochromatography; Rabies vaccine; Rabies virus; Virus neutralizing antibody

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE;

ACCURACY; ADULT; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOASSAY; JAPAN; MALE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RABIES VIRUS; RAPID FLUORESCENT FOCUS INHIBITION TEST; RAPID NEUTRALIZING ANTIBODY DETECTION TEST; SRI LANKA; THAILAND; WORLD HEALTH ORGANIZATION;

ADULT; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; DOGS; FEMALE; HUMANS; IMMUNOCHROMATOGRAPHY; JAPAN; MALE; NEUTRALIZATION TESTS; RABIES; RABIES VIRUS; SRI LANKA; THAILAND;

EID: 84861193473     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.003     Document Type: Article

References (34)

1. WHO Expert Consultation on rabies. World Health Organ Tech Rep Ser 931; 2005.
2. Knobel D., Cleaveland S., Coleman P., Fèvre E., Meltzer M., Miranda M., et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005, 83:360-368.
3. Bourhy H., Dautry-Varsat A., Hotez P.J., Salomon J. Rabies, still neglected after 125 years of vaccination. PLoS Negl Trop Dis 2010, 4(11):e839.
4. Blueprint for Rabies Prevention and Control. Official Web Site; 2010. Available: http://www.rabiesblueprint.com/.
5. Smith J.S., Yager P.A., Baer G.M. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 1973, 48(5):535-541.
6. Cliquet F., Aubert M., Sagné L. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods 1998, 212(1):79-87.
7. Feyssaguet M., Dacheux L., Audry L., Compoint A., Morize J., Blanchard I., et al. Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people. Vaccine 2007, 25:2244-2251.
8. Cliquet F., Sagné L., Schereffer J.L., Aubert M.F. ELISA test for rabies antibody titration in orally vaccinated foxes sampled in the fields. Vaccine 2000, 18(28):3272-3279.
9. Moore S.M., Hanlon C.A. Rabies-specific antibodies: measuring surrogates of protection against a fatal disease. PLoS Negl Trop Dis 2010, 4(3):e595.
10. Welch R.J., Anderson B.L., Litwin C.M. An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies. J Med Microbiol 2009, 58(Pt 6):806-810.
11. Shiota S., Mannen K., Matsumoto T., Yamada K., Yasui T., Takayama K., et al. Development and evaluation of a rapid neutralizing antibody test for rabies. J Virol Methods 2009, 161(1):58-62.
12. Kahn S., Stuardo L., Rahman S.A. OIE guidelines on dog population control. Dev Biol (Basel) 2008, 131:511-516.
13. Cliquet F., Müller T., Mutinelli F., Geronutti S., Brochier B., Selhorst T., et al. Standardisation and establishment of a rabies ELISA test in European laboratories for assessing the efficacy of oral fox vaccination campaigns. Vaccine 2003, 21(21-22):2986-2993.
14. Servat A., Cliquet F. Collaborative study to evaluate a new ELISA test to monitor the effectiveness of rabies vaccination in domestic carnivores. Virus Res 2006, 120(1-2):17-27. OIE Reference Laboratory for Rabies WHO.
15. Shrout P.E., Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979, 86:420-428.
16. Kundel H.L., Polansky M. Measurement of observer agreement. Radiology 2003, 228:303-308.
17. Wang H., Feng N., Yang S., Wang C., Wang T., Gao Y., et al. A rapid immunochromatographic test strip for detecting rabies virus antibody. J Virol Methods 2010, 170:80-85.
18. Maradei E., La Torre J., Robiolo B., Esteves J., Seki C., Pedemonte A., et al. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. Vaccine 2008, 26:6577-6586.
19. Nigg A.J., Walker P.L. Overview, prevention, and treatment of rabies. Pharmacotherapy 2009, 29:1182-1195.
20. Mills D.J., Lau C.L., Fearnley E.J., Weinstein P. The immunogenicity of a modified intradermal pre-exposure rabies vaccination schedule-a case series of 420 travelers. J Travel Med 2011, 18:327-332.
21. Suwansrinon K., Wilde H., Benjavongkulchai M., Banjongkasaena U., Lertjarutorn S., Boonchang S., et al. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. Vaccine 2006, 24(18):3878-3880.
22. Vien N.C., Feroldi E., Lang J. Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children. Trans R Soc Trop Med Hyg 2008, 102:294-296.
23. Gautret P., Parola P. Rabies vaccination for international travelers. Vaccine 2012, 30:126-133.
24. Ranney M., Partridge R., Jay G.D., Rozzoli D.E., Pandey P. Rabies antibody seroprotection rates among travelers in Nepal: rabies seroprotection in travelers. J Travel Med 2006, 13:329-333.
25. Dodet B. The Rabies in Asia conference (RIACON). Conference proceedings, Hanoi 2009, the Asian Rabies Expert Bureau.
26. Dobardzic A., Izurieta H., Woo E.J., Iskander J., Shadomy S., Rupprecht C., et al. Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005. Vaccine 2007, 25(21):4244-4251.
27. Fishbein D.B., Yenne K.M., Dreesen D.W., Teplis C.F., Mehta N., Briggs D.J. Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationwide prospective study. Vaccine 1993, 11(14):1390-1394.
28. Rupprecht C.E., Briggs D., Brown C.M., Franka R., Katz S.L., Kerr H.D., et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010, 59(RR-2):1-9.
29. Gelinck L.B., Jol-van der Zijde C.M., Jansen-Hoogendijk A.M., Brinkman D.M., van Dissel J.T., van Tol M.J., et al. Restoration of the antibody response upon rabies vaccination in HIV-infected patients treated with HAART. AIDS 2009, 23:2451-2458.
30. Suwansrinon K., Wilde H., Benjavongkulchai M., Banjongkasaena U., Lertjarutorn S., Boonchang S., et al. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity. Vaccine 2006, 24:3878-3880.
31. Hampson K., Dobson A., Kaare M., Dushoff J., Magoto M., Sindoya E., et al. Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies. PLoS Negl Trop Dis 2008, 2(11):e339.
32. Takahashi-Omoe H., Omoe K., Okabe N. Regulatory systems for prevention and control of rabies, Japan. Emerg Infect Dis 2008, 14:1368-1374.
33. Zhang Y.Z., Xiong C.L., Lin X.D., Zhou D.J., Jiang R.J., Xiao Q.Y., et al. Genetic diversity of Chinese rabies viruses: evidence for the presence of two distinct clades in China. Infect Genet Evol 2009, 9(1):87-96.
34. Khawplod P., Jaijaroensup W., Sawangvaree A., Prakongsri S., Wilde H. One clinic visit for pre-exposure rabies vaccination (a preliminary one year study). Vaccine 2012, 30(19):2918-2920.